| 2024-06-14 | Syndax Pharmaceuticals, Inc. SNDX | Chief Financial Officer | 1,250 0.0015% | $20.03 | $25,037 | -2.19% | ||
| 2023-06-13 | Sale | Syndax Pharmaceuticals, Inc. SNDX | Chief Financial Officer | 577 0.0008% | $22.31 | $12,873 | -8.2% | |
| 2022-03-16 | Sale | OptiNose, Inc. OPTN | Chief Financial Officer | 4,617 0.0056% | $2.11 | $9,742 | +16.19% | |
| 2021-12-16 | Sale | OptiNose, Inc. OPTN | Chief Financial Officer | 580 0.0009% | $1.64 | $951 | +64.51% | |
| 2021-09-16 | Sale | OptiNose, Inc. OPTN | Chief Financial Officer | 578 0.0011% | $2.79 | $1,612 | -7.04% | |
| 2021-06-17 | Sale | OptiNose, Inc. OPTN | Chief Financial Officer | 576 0.0011% | $3.73 | $2,148 | -29.73% | |
| 2021-03-15 | Sale | OptiNose, Inc. OPTN | Chief Financial Officer | 2,304 0.0044% | $3.92 | $9,032 | -27.39% | |
| 2020-09-23 | OptiNose, Inc. OPTN | Chief Financial Officer | 5,000 0.0103% | $3.90 | $19,485 | -6.57% |